Biotricity Inc. financial data

Symbol
BTCY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
203 Redwood Parkway, Suite 600, Redwood City, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
METASOLUTIONS, INC. (to 1/5/2016)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 19.9 % -46.5%
Quick Ratio 9.19 % -45.2%
Debt-to-equity -113 % +12.8%
Return On Equity 40.8 % -46.5%
Return On Assets -221 % +11.3%
Operating Margin -45.6 % +57.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares +156%
Common Stock, Shares, Outstanding 22.9M shares +167%
Entity Public Float 16.3M USD -49.9%
Common Stock, Value, Issued 23K USD +161%
Weighted Average Number of Shares Outstanding, Basic 22.5M shares +156%
Weighted Average Number of Shares Outstanding, Diluted 22.5M shares +156%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.6M USD +13.6%
Cost of Revenue 3.36M USD -21.2%
Research and Development Expense 2.19M USD -26.7%
General and Administrative Expense 20.5M USD +17.9%
Operating Income (Loss) -5.75M USD +51.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.2M USD +24.8%
Net Income (Loss) Attributable to Parent -12.2M USD +24.8%
Earnings Per Share, Basic -1.37 USD/shares +43.9%
Earnings Per Share, Diluted -1.37 USD/shares +43.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 173K USD -85.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.5M USD -6.84%
Inventory, Net 1.82M USD -14.6%
Assets, Current 4.06M USD -21.5%
Property, Plant and Equipment, Net 12.6K USD -32.1%
Operating Lease, Right-of-Use Asset 1.02M USD -27.4%
Assets 5.29M USD -22.4%
Accrued Liabilities, Current 4.23M USD +99.7%
Liabilities, Current 21.5M USD +20.6%
Operating Lease, Liability, Noncurrent 674K USD -42.3%
Liabilities 34.2M USD +5.81%
Accumulated Other Comprehensive Income (Loss), Net of Tax -73.4K USD -54.9%
Retained Earnings (Accumulated Deficit) -136M USD -13.4%
Stockholders' Equity Attributable to Parent -31.2M USD -16.6%
Liabilities and Equity 5.29M USD -22.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD +18.4%
Net Cash Provided by (Used in) Financing Activities 868K USD -34.7%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 22.9M shares +167%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.86M USD -143%
Interest Paid, Excluding Capitalized Interest, Operating Activities 707K USD +173%
Deferred Tax Assets, Valuation Allowance 18.2M USD +18.1%
Operating Lease, Liability 1.17M USD -23.8%
Depreciation 5.95K USD -0.02%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.1M USD +5.81%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD
Property, Plant and Equipment, Gross 29.8K USD 0%
Operating Lease, Liability, Current 493K USD +35.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 565K USD -5.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 600K USD +8.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 551K USD +84.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 565K USD -5.82%
Preferred Stock, Shares Issued 1 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 565K USD
Additional Paid in Capital 105M USD +12.3%
Preferred Stock, Shares Outstanding 1 shares 0%
Interest Expense 3.13M USD +27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%